Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Fecal Calprotectin Before and After Anti-Tnf Therapy in Patients With Inflammatory Bowel Diseases



Daryani NE1 ; Pishgar E2 ; Ivanaki FA1 ; Almasi F3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Gastrointestinal and Liver Diseases Research Center, Iran University of Medical science, Tehran, Iran
  3. 3. Department of Internal Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Govaresh Published:2021

Abstract

Background: Ulcerative colitis (UC) and Crohn’s disease are chronic relapsing disorders in which their clinical activity and treatment response are evaluated by various indices. The response rate is unpredictable, and for its evaluation, we use invasive procedures like colonoscopy and blood samples to address this issue. The current study was designed to evaluate the accuracy of fecal calprotectin before and after treatment with anti-tumor necrosis factor (TNF) in patients with inflammatory bowel disease (IBD). Materials and Methods: 46 patients with IBD who were a candidate for anti-TNF therapies were evaluated and the correlation between fecal calprotectin and disease activity before and after 5 months of treatment was studied. Results: Fecal calprotectin and disease activity after treatment with anti-TNF correlate, but before treatment, there was no correlation in the patients with UC. Conclusion: Fecal calprotectin not on its own but alongside other tests could be used for follow-up treatment. © 2021 Iranian Association of Gastroenterology and Hepatology. All rights reserved.